Predictive Factors for Roux Stasis Syndrome (PFRSS)

June 2, 2021 updated by: Wei Fu, Peking University Third Hospital

Predictive Factors for Roux Stasis Syndrome After Distal Gastrectomy With Roux-en-Y Reconstruction in Gastric Cancer Patients: A Retrospective Comparative Cohort

Patients who were pathologically diagnosed with gastric cancer and underwent distal gastrectomy with R-Y reconstruction between March 2014 and March 2021 were retrospectively analyzed. The occurrence of RSS was evaluated and examined for correlations with demographic and clinicopathological data. "R" package was used to build a nomogram.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Patient Selection Ethical approval for this study was obtained from the medical ethics research committee of Peking University Third Hospital (IRB00006761-2019173).

Consecutive patients who were pathologically diagnosed with gastric cancer and underwent distal gastrectomy with R-Y reconstruction between March 2014 and March 2021 at Peking University Third Hospital were retrospectively selected (the detailed screening process was shown in Figure 1).

The exclusion criteria for this study were: (1) patients with distant metastasis, (2) patients with palliative surgery, (3) death occurred within 14 days after operation, (4) patients with primary malignant disease in other organs besides stomach.

Surgical Procedure RY reconstruction was performed after standard distal gastrectomy and D2 lymph node dissection. There are several key steps involved in the RY reconstruction process. Firstly, the jejunum was dissected at 20.2cm (average value) distal to Treitz's ligament. Secondly, a side-to-side antecolic gastrojejunostomy was created using a linear stapler between the gastric stump and the distal segment of jejunum. Finally, an end-to-side or side-to-side jejunostomy was performed in output limb at about 37.2cm (average value) distal to the gastrojejunostomy (Figure 2). A cholecystectomy was performed if the patient had gallbladder-related disease.

Data collection We divided these patients into two group depending on whether RSS occurred and retrospectively analyzed the following items: gender, age, body mass index (BMI), smoking, diabetes, high carcinoembryonic antigen (CEA), hypoproteinemia, hyperlipidemia, operation approach, operation time, cholecystectomy, length of input and output loops, intestinal anastomosis approach, pathological T (pT) stage, lymph node metastasis, pathological stage, lymphovascular invasion, nerve invasion and postoperative hospital stay. According to the standard classification of BMI in China11, we divided patients into three groups, including underweight group (BMI < 18.5 kg/m2), obesity group (BMI ≥ 28.0 kg/m2) and normal group (18.5 kg/m2 ≥ BMI < 28.0 kg/m2). The cancer stage was defined according to the 8th cancer Edition Cancer Staging System presented by American Joint Committee on Cancer.

Identification of RSS We defined RSS as (1) the presence of symptoms such as nausea, vomiting, or abdominal fullness, (2) refasting after liquid or semi-liquid diets, (3) imaging methods (X-ray, CT, upper gastroenterography) confirmed without mechanical obstruction. All three conditions must be met at the same time and should occur within 30 days after operation.

Two gastroenterologists screened each patient one by one according to the RSS definition. The third gastroenterologist discussed the inconsistent patients and jointly confirmed whether the patient had RSS.

Statistical Analysis Statistical analysis was performed using the SPSS Statistics version 26.0 software program (IBM, USA). Qualitative data were compared using the chi-square test or Fisher's exact test. Quantitative data were tested by nonparametric test with Mann-Whitney U test. We choose the variables with P < 0.1 in univariate analysis and the variables that may be related to RSS clinically to be included in multivariate analysis, using Binary logistic regression analysis (Forward Conditional). Box-Tidwell method was used to verify that the continuous independent variable and the dependent variable logit transform value to be linear relationship (p > 0.05). Linear regression was used to verify that there was no multicollinearity between each independent variable (Tolerance > 0.1, VIF < 10). Based on the logistic regression results, a nomogram for predicting RSS occurrence after radical gastrectomy for distal gastrectomy with RY anastomosis was established, and performance was quantified to determine discrimination and calibration. The model was internally validated using the 1,000 bootstrapping method to obtain relatively unbiased estimates. Nomogram was built using the "rms" package in R version 3.5.2.All tests were bilateral, and P < 0.05 was considered statistically significant.

Study Type

Observational

Enrollment (Actual)

220

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100191
        • General Surgery Department, Peking University Third Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Consecutive patients who were pathologically diagnosed with gastric cancer and underwent distal gastrectomy with R-Y reconstruction between March 2014 and March 2021 at Peking University Third Hospital were retrospectively selected

Description

Inclusion Criteria:

  • pathologically diagnosed with gastric cancer
  • underwent distal gastrectomy with R-Y reconstruction
  • the date of admission is between March 2014 and March 2021
  • the admission place is Peking University Third Hospital.

Exclusion Criteria:

  • patients with distant metastasis
  • patients with palliative surgery
  • death occurred within 14 days after operation
  • patients with primary malignant disease in other organs besides stomach.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
RSS- Group
Patients without RSS after distal gastrectomy.
We defined RSS as (1) the presence of symptoms such as nausea, vomiting, or abdominal fullness, (2) refasting after liquid or semi-liquid diets, (3) imaging methods (X-ray, CT, upper gastroenterography) confirmed without mechanical obstruction. All three conditions must be met at the same time and should occur within 30 days after operation.
Other Names:
  • CT and Upper Gastroenterography
RSS+ Group
Patients with RSS after distal gastrectomy.
We defined RSS as (1) the presence of symptoms such as nausea, vomiting, or abdominal fullness, (2) refasting after liquid or semi-liquid diets, (3) imaging methods (X-ray, CT, upper gastroenterography) confirmed without mechanical obstruction. All three conditions must be met at the same time and should occur within 30 days after operation.
Other Names:
  • CT and Upper Gastroenterography

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Roux stasis syndrome
Time Frame: 2014.03.01 to 2021.03.01
Yes or No. We defined RSS as (1) the presence of symptoms such as nausea, vomiting, or abdominal fullness, (2) refasting after liquid or semi-liquid diets, (3) imaging methods (X-ray, CT, upper gastroenterography) confirmed without mechanical obstruction. If all three conditions meet at the same time and occur within 30 days after operation, we choose Yes, otherwise, we choose No.
2014.03.01 to 2021.03.01

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: 2014.03.01 to 2021.03.01
unit: years. Checking the admission record.
2014.03.01 to 2021.03.01
body mass index (BMI)
Time Frame: 2014.03.01 to 2021.03.01
unit: kg/m^2. Checking the admission record, get the information of weight in kilograms and height in meters, weight/height^2 get the BMI.
2014.03.01 to 2021.03.01
smoking, diabetes
Time Frame: 2014.03.01 to 2021.03.01
Yes or No. Checking the admission record for a history of smoking and diabetes.
2014.03.01 to 2021.03.01
operation approach
Time Frame: 2014.03.01 to 2021.03.01
Open or Laparoscopic. Checking the surgery record.
2014.03.01 to 2021.03.01
operation time
Time Frame: 2014.03.01 to 2021.03.01
unit: min. Checking the anesthesia record.
2014.03.01 to 2021.03.01
cholecystectomy
Time Frame: 2014.03.01 to 2021.03.01
Yes or No. Checking the surgery record to determine if cholecystectomy is complicating.
2014.03.01 to 2021.03.01
high carcinoembryonic antigen (CEA)
Time Frame: 2014.03.01 to 2021.03.01
Yes or No. Checking preoperative laboratory values, if CEA < 5.0 ng/ml choose No, if CEA ≥ 5.0 ng/ml, choose Yes.
2014.03.01 to 2021.03.01
hypoproteinemia
Time Frame: 2014.03.01 to 2021.03.01
Yes or No. Checking preoperative laboratory values, if albumin < 30.0 g/l choose Yes, if albumin ≥ 30.0 g/l , choose No.
2014.03.01 to 2021.03.01
length of input and output loops
Time Frame: 2014.03.01 to 2021.03.01
unit: cm. Checking the surgery record.
2014.03.01 to 2021.03.01
intestinal anastomosis approach
Time Frame: 2014.03.01 to 2021.03.01
End-to-side or Side-to-side. Checking the surgery record.
2014.03.01 to 2021.03.01
pathological T (pT) stage
Time Frame: 2014.03.01 to 2021.03.01
I or II or III. Checking the postoperative pathological report. The cancer stage was defined according to the 8th cancer Edition Cancer Staging System presented by American Joint Committee on Cancer.
2014.03.01 to 2021.03.01
lymph node metastasis, lymphovascular invasion, nerve invasion.
Time Frame: 2014.03.01 to 2021.03.01
Yes or NO. Checking the postoperative pathological report.
2014.03.01 to 2021.03.01
postoperative hospital stay
Time Frame: 2014.03.01 to 2021.03.01
unit: days. Checking the surgery and discharge record. The length of postoperative hospital stay is obtained by subtracting the date of discharge from the date of surgery.
2014.03.01 to 2021.03.01
Gender
Time Frame: 2014.03.01 to 2021.03.01
Male or Female. Checking the admission record.
2014.03.01 to 2021.03.01

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wei Fu, MD, General Surgery Department, Peking University Third Hospital
  • Principal Investigator: Xin Zhou, MD, eneral Surgery Department, Peking University Third Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 1, 2014

Primary Completion (ACTUAL)

March 1, 2021

Study Completion (ACTUAL)

May 1, 2021

Study Registration Dates

First Submitted

May 27, 2021

First Submitted That Met QC Criteria

June 2, 2021

First Posted (ACTUAL)

June 9, 2021

Study Record Updates

Last Update Posted (ACTUAL)

June 9, 2021

Last Update Submitted That Met QC Criteria

June 2, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

We may upload our raw data to Mendeley Data after accepted.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastrostomy

Clinical Trials on X-ray

3
Subscribe